GYRE THERAPEUTICS ANNOUNCES FIRST DOSING IN PHASE 1 TRIAL OF F230 FOR PULMONARY ARTERIAL HYPERTENSION IN CHINA

Reuters · 06/10 11:00

Please log in to view news